IHS Chemical Week

Regions :: North America :: U.S.

NPIL and Napo Codevelop Drug

1:40 PM MDT | February 7, 2007 | Chemical Week Editorial Staff

Napo Pharmaceuticals (San Francisco) and Nicholas Piramal India Ltd. (NPIL; Mumbai) say they have entered into a plant-screening agreement to discover novel therapeutic compounds for treating diabetes. NPIL will use its screening facility and natural product chemistry expertize, along with its biological testing capabilities, to identify active compounds from Napo’s library of medicinal plant extracts from tropical regions. Napo and NPIL will jointly own all products that are developed under the agreement. “This agreement allows us to use our advanced...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa